World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
42320
World Ranking
7316
National Ranking
3829

Nezam H. Afdhal publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Nezam H. Afdhal sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 551 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Nezam H. Afdhal D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Nezam H. Afdhal sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Nezam H. Afdhal is affiliated with Beth Israel Deaconess Medical Center in the United States and has contributed extensively to the field of medicine, with a particular focus on hepatology. Their research spans several specific subfields including hepatology, epidemiology, infectious diseases, rheumatology, and genetics.

The scientist has published numerous papers, with a significant subset addressing liver disease diagnosis and treatment, hepatitis C virus research, hepatitis B virus studies, liver disease and transplantation, liver diseases and immunity, systemic lupus erythematosus research, and HIV/AIDS drug development and treatment.

Some recent notable publications include:

  • "Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis," 2021, Hepatology
  • "Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis," 2022, Gut
  • "Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease," 2022, The American Journal of Gastroenterology
  • "Fibrosis-4 Index as an Independent Predictor of Mortality and Liver-Related Outcomes in NAFLD," 2021, Hepatology Communications
  • "A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis," 2021, Hepatology

Throughout their career, the scientist has frequently published in several venues including:

  • Journal of Hepatology
  • UNC Libraries
  • Hepatology Communications
  • Value in Health
  • Hepatology

Frequent collaborative partnerships have been established with several researchers in the field. Key coauthors include:

  • Scott Milligan
  • Zobair M. Younossi
  • Michael P. Curry
  • Michelle Lai
  • Andrew Frick

The main scientific contribution of Nezam H. Afdhal centers on liver diseases, with particular attention to nonalcoholic fatty liver disease, viral hepatitis, and pathological mechanisms related to liver fibrosis and cirrhosis. Their work also intersects with cardiovascular risks associated with liver conditions and employs modern approaches such as machine learning for clinical predictions.

Best Publications

  • Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

    Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier

  • Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

    Patrick Marcellin;Edward J Gane;Maria Buti;Nezam H Afdhal

  • Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

    Nezam Afdhal;K. Rajender Reddy;David R. Nelson;Eric Lawitz

  • Response-guided Telaprevir Combination Treatment for Hepatitis C Virus Infection

    Kenneth K.E. Sherman;Steven S.L. Flamm;Nezam N.H. Afdhal;David Nelson

  • Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

    Graham R. Foster;Nezam Afdhal;Stuart K. Roberts;Norbert Bräu

  • Telaprevir for previously treated chronic HCV infection.

    John G. McHutchison;Michael P. Manns;Andrew J. Muir;Norah A. Terrault

  • Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

    Alexander J. Thompson;Andrew J. Muir;Andrew J. Muir;Mark S. Sulkowski;Dongliang Ge

  • Evaluation of liver fibrosis: a concise review.

    Nezam H Afdhal;David Nunes

  • Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

    Michael Charlton;Gregory T. Everson;Steven L. Flamm;Princy Kumar

  • Thrombocytopenia associated with chronic liver disease

    Nezam Afdhal;John McHutchison;Robert Brown;Ira Jacobson

  • Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

    Hari S. Conjeevaram;Michael W. Fried;Lennox J. Jeffers;Norah A. Terrault

  • Diagnosis and quantitation of fibrosis.

    Diarmuid S. Manning;Nezam H. Afdhal

  • Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.

    John G. McHutchison;Geoffrey Dusheiko;Mitchell L. Shiffman;Maribel Rodriguez-Torres

  • Helicobacter pylori moves through mucus by reducing mucin viscoelasticity

    Jonathan P. Celli;Bradley S. Turner;Nezam H. Afdhal;Sarah Keates

  • The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

    Rohit Loomba;Eric Lawitz;Parvez S. Mantry;Saumya Jayakumar

  • The natural history of hepatitis C.

    Nezam H Afdhal

  • IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C

    Thomas J. Urban;Alexander J. Thompson;Shelton S. Bradrick;Jacques Fellay

  • Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.

    Nezam H. Afdhal;Douglas T. Dieterich;Paul J. Pockros;Eugene R. Schiff

  • The clinical significance of persistently normal ALT in chronic hepatitis B infection.

    Michelle Lai;Benjamin J. Hyatt;Imad Nasser;Michael Curry

  • Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

    Michael P. Curry;Xavier Forns;Raymond T. Chung;Norah A. Terrault

Frequent Co-Authors

John G. McHutchison
John G. McHutchison Duke University
Zobair M. Younossi
Zobair M. Younossi Inova Health System
Mark S. Sulkowski
Mark S. Sulkowski Johns Hopkins University School of Medicine
Bruce R. Bacon
Bruce R. Bacon Saint Louis University
Ira M. Jacobson
Ira M. Jacobson New York University
Andrew J. Muir
Andrew J. Muir Duke University
Eric Lawitz
Eric Lawitz The University of Texas at Austin
Zachary Goodman
Zachary Goodman Inova Fairfax Hospital
Mitchell L. Shiffman
Mitchell L. Shiffman Bon Secours Health System
K. Rajender Reddy
K. Rajender Reddy University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare, but not sure if medical school is the right path? There are flexible online degrees and alternative careers that may suit your goals and lifestyle. Many students explore roles in administration, nursing, or health technology, which offer rewarding opportunities and competitive salaries.

For those who want to help healthcare systems run smoothly, consider exploring healthcare administration degree programs. These online options can fast-track your entry into management roles. If you’d like to support the medical field through technology, medical billing and coding schools online with financial aid make a practical starting point—no patient care required.

Aspiring nurses can benefit from lpn program no entrance exam options, lowering admission barriers and making it easier to enter healthcare quickly. For registered nurses seeking career advancement, rn to np bridge programs offer a seamless transition to become a nurse practitioner online.

Each of these pathways offers flexibility and expanded career prospects for those passionate about making a difference in healthcare.

Best Scientists Citing Nezam H. Afdhal

Trending Scientists

Recently Published Articles